Show
Sort by
-
Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4
-
Physiological aspects determining the pharmacokinetic properties of drugs in "The Practice of Medicinal Chemistry" (3rd Edition)
-
Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: A case series
-
Comparative kinetics of the uremic toxin p-cresol versus creatinine in rats with and without renal failure
-
The influence of endotoxemia on the pharmacokinetics and the electroencephalographic effect of propofol in the rat
-
Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat
-
Tolerance to the hypnotic and electroencephalographic effect of gamma-hydroxybutyrate in the rat: pharmacokinetic and pharmacodynamic aspects
-
Urinary excretion of the uraemic toxin p-cresol in the rat : contribution of glucuronidation to its metabolization
-
Medical problems related to recreational drug use at nocturnal dance parties
-
Influence of hypovolemia on the pharmacokinetics and electroencephalographic effect of gamma-hydroxybutyrate in the rat